Bioprosthetic aortic valve replacement: a telltale from the young.

Patients younger than 50 years of age constitute 20% of overall patients with severe aortic valve disease (1). This represents a challenge perhaps due to the choice of the prosthesis elected and the need to provide the patient with some degree of balanced quality of life, interspersed with maintaining and upholding an extent of their life routine and engagements.